Nissan Medical Industries Ltd (NISA.TA)
ILA 1121.0
(-1.32%)
ILA 1121.0
(-1.32%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 351.19 Million ILS | -13.08% |
| 2022 | 404.02 Million ILS | 4.66% |
| 2021 | 386.02 Million ILS | 2.5% |
| 2020 | 376.59 Million ILS | -9.43% |
| 2019 | 415.81 Million ILS | -10.32% |
| 2018 | 463.65 Million ILS | -2.64% |
| 2017 | 476.23 Million ILS | -13.0% |
| 2016 | 547.39 Million ILS | 3.62% |
| 2015 | 528.24 Million ILS | 45.27% |
| 2014 | 363.64 Million ILS | 2.69% |
| 2013 | 354.11 Million ILS | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 352.21 Million ILS | 5.48% |
| 2024 Q1 | 333.91 Million ILS | -4.92% |
| 2023 Q3 | 401.51 Million ILS | 2.95% |
| 2023 FY | 351.19 Million ILS | -13.08% |
| 2023 Q1 | 407.59 Million ILS | 0.88% |
| 2023 Q4 | 351.19 Million ILS | -12.53% |
| 2023 Q2 | 390.01 Million ILS | -4.31% |
| 2022 Q1 | 428.12 Million ILS | 10.91% |
| 2022 FY | 404.02 Million ILS | 4.66% |
| 2022 Q4 | 404.02 Million ILS | -13.0% |
| 2022 Q3 | 464.37 Million ILS | 2.88% |
| 2022 Q2 | 451.37 Million ILS | 5.43% |
| 2021 Q2 | 382.18 Million ILS | -4.28% |
| 2021 FY | 386.02 Million ILS | 2.5% |
| 2021 Q1 | 399.27 Million ILS | 6.02% |
| 2021 Q4 | 386.02 Million ILS | -0.08% |
| 2021 Q3 | 386.33 Million ILS | 1.08% |
| 2020 Q3 | 397.53 Million ILS | -8.57% |
| 2020 FY | 376.59 Million ILS | -9.43% |
| 2020 Q2 | 434.8 Million ILS | -3.92% |
| 2020 Q1 | 452.53 Million ILS | 8.83% |
| 2020 Q4 | 376.59 Million ILS | -5.27% |
| 2019 Q4 | 415.81 Million ILS | -3.93% |
| 2019 Q2 | 442.14 Million ILS | -3.49% |
| 2019 Q1 | 458.13 Million ILS | -1.19% |
| 2019 FY | 415.81 Million ILS | -10.32% |
| 2019 Q3 | 432.82 Million ILS | -2.11% |
| 2018 Q1 | 465.32 Million ILS | -2.29% |
| 2018 FY | 463.65 Million ILS | -2.64% |
| 2018 Q3 | 462.31 Million ILS | -1.77% |
| 2018 Q2 | 470.64 Million ILS | 1.14% |
| 2018 Q4 | 463.65 Million ILS | 0.29% |
| 2017 Q1 | 529.67 Million ILS | -3.24% |
| 2017 Q4 | 476.23 Million ILS | -6.43% |
| 2017 Q3 | 508.97 Million ILS | -2.47% |
| 2017 Q2 | 521.86 Million ILS | -1.47% |
| 2017 FY | 476.23 Million ILS | -13.0% |
| 2016 Q3 | 528.97 Million ILS | -3.12% |
| 2016 Q1 | 545.62 Million ILS | 3.29% |
| 2016 FY | 547.39 Million ILS | 3.62% |
| 2016 Q4 | 547.39 Million ILS | 3.48% |
| 2016 Q2 | 545.99 Million ILS | 0.07% |
| 2015 Q4 | 528.24 Million ILS | 9.49% |
| 2015 Q3 | 482.44 Million ILS | 13.94% |
| 2015 Q1 | 372.86 Million ILS | 2.54% |
| 2015 Q2 | 423.42 Million ILS | 13.56% |
| 2015 FY | 528.24 Million ILS | 45.27% |
| 2014 Q2 | 338.26 Million ILS | 0.78% |
| 2014 Q3 | 345.17 Million ILS | 2.04% |
| 2014 Q4 | 363.64 Million ILS | 5.35% |
| 2014 FY | 363.64 Million ILS | 2.69% |
| 2014 Q1 | 335.65 Million ILS | -5.21% |
| 2013 Q2 | 351.3 Million ILS | -2.09% |
| 2013 Q4 | 354.11 Million ILS | 4.59% |
| 2013 Q1 | 358.8 Million ILS | 0.0% |
| 2013 FY | 354.11 Million ILS | 0.0% |
| 2013 Q3 | 338.57 Million ILS | -3.62% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|